Everyone is raving about the slimming power of semaglutide medications like Ozempic and Wegovy, which experts say is as ...

When someone tells me their doctor diagnosed them with prediabetes, I often witness one of two responses: panic (“I have to fix this right now!”) or deer-frozen-in-the-headlights. Both ...

Rybelsus is an oral glucagon-like peptide-1 (GLP-1) agonist and sibling medication to Ozempic and Wegovy. Per a phase 3 trial, Rybelsus was found to reduce cardiovascular risk among patients with ...

Now, a Bloomberg report says the company tested an app that helps people with prediabetes better manage their condition. Citing anonymous Apple sources, Bloomberg notes the app required Apple ...

Apple Inc., seeking to make further inroads in health care, tested an app this year to help people with prediabetes manage their food intake and make lifestyle changes, according to people with ...

Roblox is making some potentially major changes that will limit what pre-teens can access and give parents more control over what their kids do on the platform, according to an email sent by the ...

Novo expects to file for a label expansion for Rybelsus in the United States and the European Union around the turn of the year. Bengaluru: Novo Nordisk's announced on Monday that an oral version of ...

On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral glucagon-like peptide-1 receptor (GLP-1R) agonist, Rybelsus, which is currently approved for type 2 ...

Credit: fcm82 / Shutterstock. On October 21, Novo Nordisk announced positive news on the cardiovascular benefits of its oral glucagon-like peptide-1 receptor (GLP-1R) agonist, Rybelsus, which is ...

Bernstein said Novo Nordisk’s (NVO) recently released SOUL study results for Rybelsus in the reduction of major cardiovascular events in diabetic patients were modest and not as robust as ...